Literature DB >> 34584231

Sensitivity and specificity of pseudocolor ultrawide field imaging in comparison to wide field fundus fluorescein angiography in detecting retinal neovascularization in diabetic retinopathy.

Swathy Haridas1, Swati Indurkhya1, Sailesh Kumar1, Anantharaman Giridhar2, Sobha Sivaprasad3.   

Abstract

OBJECTIVE: To evaluate the diagnostic accuracy of ultrawide pseudocolor retinal photography (pseudocolor UWF) compared to wide field fundus fluorescein angiography (WFFFA) in the detection of retinal neovascularization (NV) and NV of the disc (NVD) in patients with diabetic retinopathy (DR).
DESIGN: Diagnostic accuracy observational study evaluating pseudocolor UWF as the index test. The reference standard was WFFFA.
SETTING: Single retinal centre in India. PARTICIPANTS: People with severe non-proliferative DR (sNPDR), early proliferative DR (ePDR) or high-risk proliferative DR (HR PDR). MAIN OUTCOME MEASURES: Sensitivity and specificity of pseudocolor UWF in the detection of NV.
RESULTS: A total of 176 eyes of 94 subjects with sNPDR, ePDR or HR PDR underwent pseudocolor UWF and WFFFA. The sensitivity and specificity of pseudocolor UWF in detecting NVE were 92.5% (95% CI 86.2-96.5) and 81% (95% CI 64.8-92.0), respectively, with moderate interobserver agreement of 0.722 (p value 0.001). The positive predictive value and negative predictive value were 83.0 (71.4-90.5) and 91.5 (84.9-95.3), respectively.
CONCLUSION: Compared to WFFFA as the gold standard, pseudocolor UWF has high sensitivity and specificity in detection of NV in all retinal quadrants and NVD. Therefore, pseudocolor UWF may be used as a non-invasive tool for screening and managing DR.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Year:  2021        PMID: 34584231      PMCID: PMC9499994          DOI: 10.1038/s41433-021-01772-y

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  17 in total

1.  A Novel Treatment for Proliferative Diabetic Retinopathy: Anti-Vascular Endothelial Growth Factor Therapy.

Authors:  Jeffrey G Gross; Adam R Glassman
Journal:  JAMA Ophthalmol       Date:  2016-01       Impact factor: 7.389

2.  Sensitivity and specificity of the optos optomap for detecting peripheral retinal lesions.

Authors:  Paul J Mackenzie; Matt Russell; Patrick E Ma; Carolyn M Isbister; David A L Maberley
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

3.  Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap).

Authors:  Aljoscha S Neubauer; Marcus Kernt; Christos Haritoglou; Siegfried G Priglinger; Anselm Kampik; Michael W Ulbig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-11       Impact factor: 3.117

4.  Classification and Guidelines for Widefield Imaging: Recommendations from the International Widefield Imaging Study Group.

Authors:  Netan Choudhry; Jay S Duker; K Bailey Freund; Szilard Kiss; Giuseppe Querques; Richard Rosen; David Sarraf; Eric H Souied; Paulo E Stanga; Giovanni Staurenghi; SriniVas R Sadda
Journal:  Ophthalmol Retina       Date:  2019-05-13

5.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs.

Authors:  Varun Gulshan; Lily Peng; Marc Coram; Martin C Stumpe; Derek Wu; Arunachalam Narayanaswamy; Subhashini Venugopalan; Kasumi Widner; Tom Madams; Jorge Cuadros; Ramasamy Kim; Rajiv Raman; Philip C Nelson; Jessica L Mega; Dale R Webster
Journal:  JAMA       Date:  2016-12-13       Impact factor: 56.272

6.  Ultra-wide field imaging in the diagnosis and management of adult-onset Coats' disease.

Authors:  Vinod Kumar; Parijat Chandra; Atul Kumar
Journal:  Clin Exp Optom       Date:  2016-07-31       Impact factor: 2.742

7.  Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.

Authors:  Sobha Sivaprasad; A Toby Prevost; Joana C Vasconcelos; Amy Riddell; Caroline Murphy; Joanna Kelly; James Bainbridge; Rhiannon Tudor-Edwards; David Hopkins; Philip Hykin
Journal:  Lancet       Date:  2017-05-07       Impact factor: 79.321

8.  Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years.

Authors:  Paolo S Silva; Jerry D Cavallerano; Nour Maya N Haddad; Hanna Kwak; Kelli H Dyer; Ahmed F Omar; Hasanain Shikari; Lloyd M Aiello; Jennifer K Sun; Lloyd Paul Aiello
Journal:  Ophthalmology       Date:  2015-02-19       Impact factor: 12.079

9.  Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.

Authors:  Anthony Obeid; Xinxiao Gao; Ferhina S Ali; Katherine E Talcott; Christopher M Aderman; Leslie Hyman; Allen C Ho; Jason Hsu
Journal:  Ophthalmology       Date:  2018-03-29       Impact factor: 12.079

10.  Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis(®) noncontact ultra-widefield module versus the Optos(®) Optomap(®).

Authors:  Matthew T Witmer; George Parlitsis; Sarju Patel; Szilárd Kiss
Journal:  Clin Ophthalmol       Date:  2013-02-21
View more
  1 in total

Review 1.  Scanning laser ophthalmoscopy retroillumination: applications and illusions.

Authors:  Martin A Mainster; Thomas Desmettre; Giuseppe Querques; Patricia L Turner; Gerardo Ledesma-Gil
Journal:  Int J Retina Vitreous       Date:  2022-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.